Tag: safety

Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial

Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial

| December 1, 2017

by Daniel M. Siegel, MD; Stephen Tyring, MD, PhD; Walter K. Nahm, MD, PhD; Marie Louise Østerdal, MSc; Astrid H. Petersen, PhD;  and Brian Berman, MD, PhD Dr. Siegel is with Long Island Skin Cancer and Dermatologic Surgery in New York, New York. Dr. Tyring is with the Center for Clinical Studies in Houston, Texas. […]

Continue Reading